Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

2026-02-08
Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.

University of Galway opens medtech prototype hub under Medtronic partnership

2026-02-06
With financial support from Medtronic, the university’s new hub is intended to drive innovation in the medical device space.

Applied Medical Prevails in Antitrust Jury Trial Against Medtronic

2026-02-06
RANCHO SANTA MARGARITA, Calif., February 06, 2026--Applied Medical Prevails in Antitrust Jury Trial Against Medtronic

UBS Makes a Modest Target Increase on Medtronic (MDT), Keeps Neutral Rating

2026-02-05
Medtronic plc (NYSE:MDT) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 4, UBS raised its price recommendation on Medtronic plc (NYSE:MDT) to $104 from $103. The firm kept a Neutral rating on the stock. A day earlier, Medtronic announced plans to acquire privately held CathWorks in a deal […]

Medtronic: A Healthier Diagnosis

2026-02-05
Medtronic plc is a diversified medtech leader with $33 billion in sales, showing resilient organic growth. Learn more about MDT stock here.

Is Medtronic (MDT) Still Reasonably Priced After Recent Share Price Gains?

2026-02-05
If you are wondering whether Medtronic at around US$101.84 is still a sensible price or starting to look stretched, you are not alone. The stock has posted returns of 1.0% over the last 7 days, 4.6% over the last 30 days, 6.0% year to date, 14.6% over 1 year and 30.4% over 3 years, with a 5 year return of 0.7%. Recent coverage has focused on Medtronic's position as a major medical devices company and how investors are weighing its product pipeline and competitive standing against the current...

Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors

2026-02-04
Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

Medtronic Expands Heart And Diabetes Tools As Valuation Nears Analyst Views

2026-02-04
Medtronic (NYSE:MDT) announced an agreement to acquire CathWorks, aiming to add AI-powered coronary artery disease tools to its interventional cardiology portfolio. The company also reported progress in diabetes care, with Medicare coverage and FDA clearance for its MiniMed 780G system paired with Abbott's Instinct sensor. These updates span Medtronic's cardiovascular and diabetes businesses, touching key areas of chronic disease management. Medtronic shares recently closed at $103.18, with...

Medtronic set to acquire CathWorks for $585m

2026-02-04
The acquisition remains subject to US Federal Trade Commission clearance and other regulatory approvals.

Silver Economy Boom: Investing in Healthcare's Aging Tailwinds

2026-02-03
An aging population is reshaping healthcare, with BSX, RMD, ABBV and AMGN positioned to benefit from rising senior care demand.